ReviewHarm reduction journal2025
50 years of harm reduction in Europe: high time for transformation.
Review in Harm reduction journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reshaping addiction harm reduction program in Iran: The Ministry of Health's journey from reactive measures to strategic optimization.Harm reduction journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Europe has been the first home for the harm reduction movement, acknowledging its values and principles relatively early, although not without challenges. Built on successful experiences starting in the early 1980s, some pioneering European countries committed, invested in and implemented a broad spectrum of harm reduction services over the years. The HIV/AIDS epidemic helped to establish a broader recognition of the effectiveness of harm reduction policies in other countries as well by the mid-1990s. However, we argue that the adoption of harm reduction is lagging behind in important ways, leading to uneven and poor implementation of services. In this perspective-paper, we highlight some reasons that may have contributed to this, and we explore how multiple societal trends and the current conceptualisation of harm reduction have hindered further acceptance and implementation. We do this by revealing assumptions underlying the concept of harm reduction. Finally, we explore how we may move harm reduction forward as a field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.